The Onco'Zine Brief with Peter Hofland

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Covert, Vice President & General Manager Targeted Drug Delivery, Restorative Therapies Group - Pain Division at Medtronic, about opioids and pain management in patients with cancer. While considered safe, reliable, and effective for all types of pain, opioids are also a potentially abuseable drugs. And the public health conseq...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Kenneth Vega, chief of Gastroenterology and co-director of the Digestive Health Center at Augusta University Health, a public research university and academic medical center located in Augusta, Georgia (USA). Hofland and Vega talk about the prevention of colorectal cancer by means of a colonoscopy. Unfortunately, many people postp...

In this edition of The Onco’Zine Brief we talk with Padma Sundar. Ms. Sundar is Vice President of Strategy and Market Access at CellMax Life, a company developing a simple blood test or liquid biopsy for cancer screening. The company is using a proprietary technology for detecting pre-cancer and cancer cells in a single blood sample. Together with a team of experts across multiple disciplines, inc...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Nader Sanai an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors, including glioblastoma, the most aggressive cancer that begins within the brain. Dr. Sanai is the director of the Ivy Brain Tumor Center at the Barrow Neurological Institute in Phoenix, Ariz...

In this edition of The Onco’Zine Brief Peter Hofland talks with Robert Goff about Medical Debt. Goff is one of the co-authors of a new book (“End Medical Debt: Curing America’s $1 Trillion Unpayable Healthcare Debt”) about the subject. He co-authored the book with Jerry Ashton and Craig Antico. In today's show Hofland and Goff talk about the problem of medical debt and how we got here. They talk a...

In the second part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com, Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona Digestive Health, in Phoenix, Arizona, and Sukhdeep S Padda, MD from Arizona Gastrointestinal Associates and Arrowhead Gastroenterology Associates, in Glendale...

In the third and final part of a 3-part series about colorectal cancer, developed in collaboration with the online journal OncoZine at www.oncozine.com, Peter Hofland, PhD. talks with Paul J. Berggreen, MD and Daniel M. Jondle, MD, both from Arizona Digestive Health, in Phoenix, Arizona, and Sukhdeep S Padda, MD from Arizona Gastrointestinal Associates and Arrowhead Gastroenterology Associates, in...

This week in The Onco’Zine Brief Peter Hofland, Ph. D talks with Guy Chamberland, M.Sc., Ph. D, about medicinal cannabis. Chamberland, is a Master Herbalist as well as Chief Executive Officer and Chief Scientific Officer of Tetra Bio-Pharma, a biopharmaceutical company developing cannabinoid-based drugs. Tetra Bio-Pharma has a clinical development program aimed at bringing novel drugs and treatmen...

In this edition of The Onco’Zine Brief Peter Hofland talks with Dr. Paul Berggreen and Dr. Daniel Jondle, both from Arizona Digestive Health, in Phoenix, Arizona, about Colorectal Cancer. Today’s program is the first of a 3-part series about the disease, which is the third most common cancer diagnosed in the United States. Colorectal Cancer is the second leading cause of death from cancers that af...

In this edition of The Onco’Zine Brief Peter Hofland talks with Charlie Johnson, Chief Executive Officer of ADC Bio, a biotechnology company, specialized in the development of Antibody-drug Conjugates. Antibody-drug Conjugates, also known as ADCs, are a novel type of targeted anticancer agents. Today 4 drugs in this class of drugs have been approved by regulators around the world, but there are mo...

In this Edition of the OncoZine Brief, recorded during the Annual meeting of American Society of Clinical Oncology (ASCO), which took place June 1-5, 2018 in Chicago Illinois, Peter Hofland and Sonia Portillo interview Dr. Sotirios Stergiopoulos, who is the Chief Medical Officer of Ipsen, a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops...

In this edition of The Onco’Zine Brief, recorded during the Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, Illinois, June 1 - 5, 2018, Peter Hofland and Sonia Portillo talk with Michael Pehl, President and Chief Executive Officer of Immunomedics, a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC). At this year’s ASCO meeting, nea...

In the edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo review some of the most exciting and important study to be presented at the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), to be held in Chicago, June 1 - 5, 2018. The theme of this year’s conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 2,500 abstracts we...

In this edition of The Onco’Zine Brief, Sonia Portillo talks with Neil Canavan about the people involved in developing novel, advanced – and sometimes – highly personalized - anti-cancer treatments. Canavan is a veteran journalist with more than 20 years of experience reporting on science and medicine. For the last 5 years he has reported exclusively on issues related to drug development in cancer...

In this Edition of the Onco'Zine Brief, Peter Hofland and Sonia Portillo talk with Dr. John B. Kisiel, Assistant Professor of Medicine and a Consultant in the, Division of Gastroenterology and Hepatology, Department of Internal Medicine at the Mayo Clinic in Rochester, Minnesota. The overall goal of Dr. Kisiel is to improve the clinical outcomes of patients with gastrointestinal illness by providi...

This week in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with experts in oncology about some of the results presented during the annual meeting for the American Society of Clinical Oncology, held in Chicago, Ill, June 1 - 5, 2018. The theme of this year’s ASCO conference is: Delivering Discoveries: Expanding the Reach of Precision Medicine. More than 40,000 people attended the meetin...

In this episode of the Onco’Zine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Col. James E. Williams who, during the annual meeting of the American Association for Cancer Research (AACR), held April 14 - 18, 2018 in Chicago, Ill, received the organization's Distinguished Public Service Award for Exceptional Leadership in Cancer Advocacy. Each year, the American Association for Cancer R...

In this edition of The Onco’Zine Brief Peter Hofland and Sonia Portillo are talking with Elizabeth M. Jaffee, MD, the 2018 - 2019 president of the American Association​ for Cancer Research (AACR). Dr. Jaffee’s, who's research is focused on the development of immune based therapies for pancreatic and breast cancers, is the deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Ho...

The Netherlands-born writer Manon Rinsma is the author of a new book called “13 Diamonds – Life before death from a Child’s Perspective. In her book, Rinsma writes about losing her mother at a very young age - something so traumatic that it completely changed how she viewed the world. Rinsma's mother died of a form of brain cancer. For her remaining family - finding an answer to the question "how...

Today in the OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Jim Ratcliff, CEO of Chairman of Rowpar Pharmaceuticals, the developer, manufacturer and marketer of best-in-class oral care products, sold under the CloSYS brand in Australia and the United States and under private label in Europe and India. In their interview with Dr. Ratcliff, Hofland and Portillo ask about the impor...

Today in The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Dr. Michael Caligiuri., MD The Interview was recorded during the 2018 annual meeting of American Association​ for Cancer Research (AACR) held April 14-18th, 2018 in Chicago, Illinois. Michael A. Caligiuri is a renowned physician-scientist known for his work in immunology that is focused on human natural killer cells and their...

This week in The Onco’Zine Brief: Peter Hofland, Ph. D and Sonia Portillo talk with Otis Brawley, MD, MACP the Chief Medical and Scientific Officer of the American Cancer Society. Hofland and Portillo ask Dr. Brawley about the past, present, and future of the fight against cancer, including screening, diagnostics and treatment with novel, targeted drugs, and the role of the American Cancer Society...

In this Edition of The Onco'Zine Brief Peter Hofland, Ph. D and Sonia Portillo talk with Joseph M. Connors, MD., FRCPC, Clinical Director, Center for Lymphoid Cancer (Retired 2018) and Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the chair of the Lymphoma Tumor Group for the British Columbia Cancer Agency Dr. Connors is a...

In this Edition of the OncoZine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Amit Kumar, Ph. D, Chairman, President & Chief Executive Officer of ITUS Corporation Executive Chairman of Anixa Diagnostics Corporation Dr. Kumar, is the inventor of the company’s Cchek™ technology for the early detection of tumor-based cancers and has been an investor, founder, director and CEO of several te...

In this episode of The Onco'Zine Brief, Peter Hofland, Ph. D and Sonia Portillo talk with Dr. Joseph M. Connors, MD., FRCPC, Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the chair of the Lymphoma Tumor Group for the British Columbia Cancer Agency. Dr. Connors is also the lead investigator of the ECHELON-1 clinical trial,...